Domain | No. Breakout Groups Selecting Domain among “Top 3” Life Impact Domains | Voted Yes | Voted No | Voted Insufficient Evidence or Information |
---|---|---|---|---|
Systemic inflammation, laboratory blood tests | Not asked | 123/142 (87%) | 4/142 (3%) | 15/142 (11%) |
Physical function | 8/8 | 137/145 (94%) | 3/145 (2%) | 5/145 (3%) |
Patient global | 1/8 | 66/144 (46%) | 41/144 (28%) | 37/144 (26%) |
Pain/ache | 8/8 | 133/145 (92%) | 4/145 (3%) | 8/145 (6%) |
Stiffness | 7/8 | 131/145 (90%) | 3/145 (2%) | 11/145 (8%) |
Fatigue | 0/8 | 74/145 (51%) | 35/145 (24%) | 36/145 (25%) |
Psychological impact | 0/8 | 50/146 (34%) | 57/146 (39%) | 39/146 (27%) |
OMERACT: Outcome Measures in Rheumatology; PMR: polymyalgia rheumatica.